Chairman of Meihua Holdings Group (600873.SH) proposed that the company allocate 300 million to 500 million yuan to repurchase shares for cancellation.

18:57 23/09/2024

Meihua Bio (600873.SH) announced that the chairman of the company, Wang Aijun, proposed that the company repurchase its own shares with its own funds...

Meihua Holdings Group (600873.SH) announced that the Chairman of the company, Wang Aijun, proposed the company to repurchase its own shares with its own funds for cancellation, in order to reduce the registered capital. The proposed price for this share repurchase is not more than RMB 12 per share. The total amount of repurchase funds shall not be less than RMB 300 million (inclusive) and not more than RMB 500 million (inclusive).

Nanjing Canatal Data-Centre Environmental Tech (603912.SH): Anle Group intends to reduce its shareholding by no more than 3%

Shanghai Fosun Pharmaceutical's subsidiary has had its drug registration application for Decitabine accepted by the National Medical Products Administration for review.

China Vanke (02202): Yu Liang resigns as Executive Director.

Nanjing Canatal Data-Centre Environmental Tech (603912.SH): Anle Group intends to reduce its shareholding by no more than 3%

Shanghai Fosun Pharmaceutical's subsidiary has had its drug registration application for Decitabine accepted by the National Medical Products Administration for review.

China Vanke (02202): Yu Liang resigns as Executive Director.